Clinical Trial Update: A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating intravenous aflibercept in combination with docetaxel in Chinese patients with malignant solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• Aflibercept (Aflibercept)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Neoplasm Malignant | Phase 1 | Status: COMPLETED